BREAKING
Eli Lilly and Company (LLY) to acquire Orna Therapeutics 52 minutes ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 2 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 2 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 3 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 5 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 5 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 6 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 6 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 6 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 52 minutes ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 2 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 2 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 3 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 5 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 5 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 6 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 6 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 6 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago
ADVERTISEMENT
Market News

Neovasc (NVCN) Q4 2019 Earnings Snapshot

— Neovasc (NASDAQ: NVCN) reported a comprehensive loss of $1.45 per share for Q4 2019 vs. a loss of $5.07 per share in the prior-year quarter. — Revenue rose 8% to $0.57 million vs. $1.16 million expected. — Expenses declined 6% to $10.03 million. — The company stated that it started the year with strong […]

$NVCN March 30, 2020 1 min read

— Neovasc (NASDAQ: NVCN) reported a comprehensive loss of $1.45 per share for Q4 2019 vs. a loss of $5.07 per share in the prior-year quarter.

— Revenue rose 8% to $0.57 million vs. $1.16 million expected.

— Expenses declined 6% to $10.03 million.

— The company stated that it started the year with strong Reducer revenues in January and February and were on track for the best revenue quarter ever, until the effects of the COVID-19 crisis were abruptly felt. 

— NVCN stock declined about 9% during the after-hours of trading.

ADVERTISEMENT

ADVERTISEMENT